Related Experiment Videos
Accurate DNA-based diagnostic and carrier testing for X-linked adrenoleukodystrophy
C D Boehm1, G R Cutting, M B Lachtermacher
1Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21287, USA.
Molecular Genetics and Metabolism
|March 9, 1999
Summary
A new DNA test accurately identifies carriers of X-linked adrenoleukodystrophy (X-ALD), a serious genetic disorder. This reliable method aids in determining carrier status for women at risk of transmitting the condition.
Area of Science:
- Genetics
- Biochemistry
- Neurology
Background:
- X-linked adrenoleukodystrophy (X-ALD) is a severe genetic disorder affecting the nervous system, adrenal cortex, and testes.
- The disease is caused by mutations in the gene encoding the peroxisomal membrane protein ALDP.
- Diagnosing carrier status in women is challenging due to biochemical test unreliability.
Purpose of the Study:
- To develop and validate a robust DNA diagnostic test for X-ALD carrier status.
- To provide an accurate method for identifying or excluding carrier status in at-risk women.
- To establish a reliable protocol for clinical diagnostic laboratories.
Main Methods:
- Developed a DNA diagnostic test using nonnested genomic amplification of the X-ALD gene.
- Employed fluorescent dye-primer sequencing and analysis for molecular diagnosis.
- Validated the protocol for accuracy and reliability in carrier status determination.
Main Results:
- The developed DNA test accurately identifies carrier status for X-ALD.
- The protocol is robust and reliable, overcoming challenges posed by autosomal paralogs.
- This method provides a definitive way to determine carrier status, unlike biochemical tests.
Conclusions:
- A validated DNA diagnostic test offers a highly reliable method for determining X-ALD carrier status in women.
- This molecular approach is applicable to clinical diagnostic settings.
- Accurate carrier identification is crucial for genetic counseling and management of X-ALD transmission.